JIIMS.cdr ABSTRACT Objective: To identify the different clinical and biochemical presentations of patients having polycystic ovarian syndrome. Study Design: A descriptive observational study. Place and Duration of Study: This study was carried out at Obstetrics and Gynaecology department of CMH Rawalpindi, from October 2010 to Sept 2011. Materials and Methods: This observational study was conducted to identify the different presentation of patients suffering from polycystic ovarian syndrome. Seventy five cases of polycystic ovarian syndrome who reported in OPD were selected for the study. Results:The patients mostly presented between 20-30 years of age with symptoms of oligomenorrhea, infertility and hirsutism. Ultrasonography showed the morphology of polycystic ovary and deranged FSH, LH and testosterone levels. Keywords: Polycystic ovarian syndrome, Oligomenorrhea, Infertility, Hirsutism. 60 ORIGINAL ARTICLE highlight the different symptoms and signs with which the patients reported in the gynaecology and obstetrics department of Combined Military Hospital, Rawalpindi over a period of one year. This descriptive study was carried out at Obstetrics and Gynecology department CMH Rawalpindi. Seventy five cases of polycystic ovarian syndrome were selected for the study. Detailed menstrual history of the patient was taken. Pelvic examination of all the married patients was carried out in all the patients. Ultrasonography pelvis was carried out in all the patients. Hormonal levels (FSH, LH, Prolactin, Testosterone, Estradiol) were also carried out. Baseline blood chemistry was done in all cases. Patients who presented with complaints of m e n s t r u a l i r re g u l a r i t i e s , i n f e r t i l i t y, hirsutism and obesity were included in the s t u d y. P a t i e n t s h a v i n g m e n s t r u a l irregularities due to other causes, like menorrhagia, and other causes of infertility, like male causes, tubal occlusion, were excluded from the study. Out of the 75 women selected for the study Materials and Methods Results Introduction Polycystic ovarian syndrome (PCOS) is associated with reproductive, metabolic and psychological dysfunction and affects 4-18% 1 of women in reproductive age group. It is the most common endocrinopathy affecting 2 women of reproductive age. There is an increased risk of diabetes, hypertension, metabolic syndrome, and endometrial 3 carcinoma. PCOS adversely affects the female reproductive health leading to infertility and miscarriages. Diagnosis of PCOS is a challenge for the clinicians and with availability of more advanced diagnostic tools the prevalence has seen to be increased because most of the 4 cases remain undiagnosed clinically. PCOS is a frequent condition in women of reproductive ageand has associated 5 metabolic dysfunction. This condition also has serious psychological implication as 6 well. The usual manifestations include irregular menses, androgen excess and 7 obesity. The aim of the present study is to ------------------------------------------------- Correspondence: Dr Nabila Amin Consultant gynecologist & Obstetrician Department of Gynae/Obs Combined Military Hospital Rawalpindi Presentations of Polycystic Ovarian Disease- Study at Tertiary Care Hospital Nabila Amin, Shazia Chohan, Farhat Kareem Table I: Presenting features of patients with PCOS 61 51 (68%) had raised LH and FSH ratio while testosterone was mildly raised in 20 patients (Table II). On ultrasonography polycystic ovaries were found in 49 (65%) patients (Table II). Most common presenting symptom wasoligomenorrhoea which was present in 75% cases (56 patients) (Table I). Fifty six perecent (42 patients) patients had infertility while hirsutism was present in 53% (39 patients) cases (Table I). Most of the patients presented in 20-30 years age group. 30 patients (40%) were found to be obese (Table I). Discussion It was in 1935 that Stein and Leventhal originally described the polycystic ovarian syndrome. PCOS is diagnosed using the 8 Rotterdam criteria, which declares that when at least two of the following three features are present the patient can be labeled as having PCOS: � oligomenorrhea/ anovulation � hyperandrogenism � Polycystic ovaries In the study Rotterdam criteria was used for diagnosing the patients of PCOS. The studyshows that the most common presenting symptom was oligomenorrhoea, this finding is similar to other studies carried out and was of almost similar level to the one 9,10 reported in US study. Similarly infertility was a very common symptom being present in 65% of our patients. This shows that married women tend to report for their concern for infertility and are subsequently diagnosed as having PCOS. The worldwide incidence of patients with infertility having 11 PCOS is about 75%. Hirsutism is again a very common symptom in patients of PCOS, it being present in 35% patients in Chinese 12 population. Obesity is more commonly present in women with PCOS of Hispanic, black and white origin while its incidence is l o w e r i n w o m e n o f M e d i t e r r a n e a n d e s c e n t . 1 3 H y p e r a n d r o g e n i s m w a s exhibited by the deranged levels of FSH, LH and testosterone as in other studies these levels play an important role in diagnosis of Table II: Investigations of patients with PCOS Figure 1: 62 1 4 PCOS. Transvaginal ultrasonography carried out showed the presence of 12 or more follicles measuring 2-9 mm in diameter and increased ovarian volume (more than 10cm3) in 65% patients, which is one of the features of PCOS according to Rotterdam criteria. The patients typically presented in 3rd decade of life. It can be concluded from this study that patients present with menstrual cyclical disturbances, infertility with and without m e n s t r u a l d i s t u r b a n c e s , a s s o c i a t e d h i r s u t i s m a n d o b e s i t y , ultrasonographicfeaturesandhormone level estimation play pivotal role in diagnosis of PCOS. 1. Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. [Meta-Analysis Review]. 2011(2): CD007506. 2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998 ; 83: 3078-82. 3. Chen ZJ, Shi Y. Polycystic ovary syndrome. Front Med China 2010; 4: 280-4. 4. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic Conclusion References criteria. Hum Reprod; 25: 544-51. 5. Moran LJ, Brinkworth GD, Norman RJ. Dietary therapy in polycystic ovary syndrome. Semin Reprod Med 2008; 26: 85-92. 6. Teede H, Deeks A, Moran L. Polycystic ovary s y n d ro m e : a c o m p l e x c o n d i t i o n w i t h psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41. 7. Zarate A, Moran C, Hernandez M, Saucedo R. [Current criterion for diagnosing polycystic ovary syndrome]. Ginecol Obstet Mex 2004; 72: 283-6. 8. Isolauri E, Huurre A, Salminen S, Impivaara O. The allergy epidemic extends beyond the past few decades. Clin Exp Allergy 2004; 34: 1007-10. 9. Najem F, Elmehdawi R, Swalem A. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study. Libyan J Med 2008; 3: 71-4. 10. Richardson MR. Current perspectives in polycystic ovary syndrome. Am Fam Physician 2003 ; 68: 697-704. 11. Lakhani K, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovaries. Br J Radiol 2002; 75: 9-16. 12. Li L, Yang D, Chen X, Chen Y, Feng S, Wang L. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet 2007; 97: 129-34. 13. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003; 18: 2289-93. 14. Hunter MH, Sterrett JJ. Polycystic ovary syndrome: it's not just infertility. Am Fam Physician. 2000; 62:1079-88, 90.